EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.
EsoBiotec has raised $2.2M in total funding. The most recent round was Series A. The last funding was announced in December 2023.
EsoBiotec's investors include Thuja Capital, Invivo Capital Partners, S.R.I.W., UCB Ventures, Sambrinvest.
EsoBiotec is headquartered in Mont-saint-guibert, Belgium.
EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.
EsoBiotec is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EsoBiotec — Funding & Investors." VCBacked, December 12, 2023, https://www.vcbacked.co/company/esobiotec. Accessed July 21, 2026.
VCBacked. (2023). EsoBiotec — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/esobiotec
{{cite web |title=EsoBiotec — Funding & Investors |url=https://www.vcbacked.co/company/esobiotec |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated